Market Size of Malaysia Insulin Infusion Pump Industry
| Study Period | 2019 - 2029 |
| Base Year For Estimation | 2023 |
| Forecast Data Period | 2024 - 2029 |
| Market Size (2024) | USD 0.81 Million |
| Market Size (2029) | USD 0.92 Million |
| CAGR (2024 - 2029) | 2.60 % |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Malaysia insulin infusion pump market analysis
The Malaysia Insulin Infusion Pump Market size is estimated at USD 0.81 million in 2024, and is expected to reach USD 0.92 million by 2029, growing at a CAGR of 2.60% during the forecast period (2024-2029).
According to the Agency for Clinical Research (ICR), a research agency affiliated with the National Institutes of Health (NIH), seven out of ten patients who died from COVID-19 in Malaysia had diabetes. The NHMS also discovered that around 8.1% of Malaysia's adult population, or 1.7 million people, have all three risk factors for diabetes, hypertension, and high cholesterol, the three major noncommunicable illnesses. Diabetes, according to STAT, is characterized by a chronic inflammatory condition that may result in a greater response to COVID-19 or an immunological overreaction that may cause organ damage. Diabetes can also compromise the immune system, and people with type-2 diabetes have more ACE2 receptors in numerous organs, making them more vulnerable to COVID-19 invasion.
Regarding diabetes gadgets, the monitoring category has a substantial market share. Over 100 million individuals worldwide need insulin, including all Type-1 diabetics and 10% to 25% of Type-2 diabetics, who are all required to regularly monitor their glucose levels. Insulin production is exceedingly complex, with just a few manufacturers on the market. As a result, there is fierce competition among these businesses, which always strive to match patient demands by providing the highest-quality insulin.
According to the National Diabetes Registry (NDR) of the Ministry of Health, 84% of diabetes patients in Malaysia are overweight, with young Malaysians aged 18 to 40 being among them. The government is currently investigating the Sama-Sama project, which aims to empower family members and carers to help individuals living with diabetes to enhance disease control and outcomes.
In reality, underlying comorbidities account for most coronavirus mortality in Malaysia, with diabetes and hypertension topping the list and driving the market throughout the forecast period.
Malaysia Insulin Infusion Pump Industry Segmentation
An insulin pump delivers insulin to control blood sugar and minimize hypoglycemia's effects. The pump comprises a pump reservoir like an insulin cartridge, a battery-operated pump, and a computer chip that allows the user to control the exact amount of insulin being delivered. The pump is attached to a thin plastic tube (an infusion set) with a soft cannula (or needle) at the end through which insulin passes. Malaysia's insulin infusion pumps market is segmented by components (pump device, infusion set, and reservoir). The report offers the value (USD) and Volume (units) for the above segments.
| Insulin Infusion Pump | |
| Insulin Pump Device | |
| Infusion Set | |
| Reservoir |
Malaysia Insulin Infusion Pump Market Size Summary
The Malaysia insulin infusion pump market is poised for gradual growth over the forecast period, driven by the increasing prevalence of diabetes and related comorbidities such as hypertension and high cholesterol. The market is characterized by a concentrated competitive landscape, with a few major global and local players like Medtronic PLC, Insulet Corporation, and Tandem Diabetes Care dominating the scene. The government's initiatives, such as the Sama-Sama project, aim to enhance disease control and outcomes for diabetes patients by empowering caregivers and family members. Additionally, collaborations between the government and private sector to train healthcare personnel are expected to bolster the market's expansion.
Despite the rising incidence of diabetes in Malaysia, the adoption of insulin pumps remains limited compared to Western countries, where they are widely used, especially among type 1 diabetics. The insulin infusion pump serves as a viable alternative to traditional insulin delivery methods, offering near-physiological insulin administration. The market's growth is further supported by the increasing awareness and prevention campaigns launched by the Malaysian government to address the diabetes epidemic. As the demand for effective diabetes management solutions continues to rise, the insulin pump market in Malaysia is anticipated to experience steady growth, albeit at a measured pace due to the existing competitive dynamics and market penetration challenges.
Malaysia Insulin Infusion Pump Market Size - Table of Contents
-
1. MARKET DYNAMICS
-
1.1 Market Overview
-
1.2 Market Drivers
-
1.3 Market Restraints
-
1.4 Porter's Five Forces Analysis
-
1.4.1 Bargaining Power of Suppliers
-
1.4.2 Bargaining Power of Consumers
-
1.4.3 Threat of New Entrants
-
1.4.4 Threat of Substitute Products and Services
-
1.4.5 Intensity of Competitive Rivalry
-
-
-
2. MARKET SEGMENTATION
-
2.1 Insulin Infusion Pump
-
2.1.1 Insulin Pump Device
-
2.1.2 Infusion Set
-
2.1.3 Reservoir
-
-
Malaysia Insulin Infusion Pump Market Size FAQs
How big is the Malaysia Insulin Infusion Pump Market?
The Malaysia Insulin Infusion Pump Market size is expected to reach USD 0.81 million in 2024 and grow at a CAGR of 2.60% to reach USD 0.92 million by 2029.
What is the current Malaysia Insulin Infusion Pump Market size?
In 2024, the Malaysia Insulin Infusion Pump Market size is expected to reach USD 0.81 million.
